Intracerebral arteriovenous malformation (AVM) is an intracranial vascular malformation that causes death or disability in patients. The incidence of AVMs is 1 per 100,000 per year in randomized populations and 18 per 100,000 in adults. The proportion of patients with AVM is approximately 1-2% in all stroke patients; 3% in adult stroke patients; 9% in all subarachnoid hemorrhages; and 4% in all patients with primary cerebral hemorrhage, but up to 1/3 in younger patients with cerebral hemorrhage.The common symptoms in patients with AVM are Sudden seizures and headache symptoms without abnormal neurological signs. The annual mortality rate of patients with AVM is 1-1.5%, and the annual risk of bleeding in unbleeding AVM is 2%, but the risk of rebleeding within one year is as high as 18% in patients who have already emitted blood.